S0003871

One Step MERISCREEN Mal Pf/Pv Ag, kit/30


Rapid diagnostic test One Step test for Malaria MERISCREEN Malaria Pf/Pv Ag, kit/30
Indicative Price 8.70 USD
Disclaimer: The images shown are for illustration purposes only and may not be an exact representation of the product. “No Generic Photo Available" means that there is not an image available for this product.

General description:
One Step test for Malaria Pf/Pv Ag MERISCREEN Malaria Pf/Pv Ag test kit is an in vitro diagnostic immunochromatographic assay for the qualitative detection of infections with Pf and Pv parasites and to differentiate infection between Pf-HRP2 and Pv-pLDH in human whole blood specimens.

Technical specifications:
Technology: Lateral immuno-chromatographic test
Format: Cassette, 30 tests
Sample type: Whole blood
Sample volume: 5µl
Pf panel detection score: 78.0%
Pv panel detection score: 85.7%
False positive rate: 0.0% for clean negatives
0.5% for Pf
0.7% for Pv
Invalid rate: 0.0%
Reading time: 20 mins. Don’t read test results after 30 minutes. Reading too late can give false results.

Manufacturer product reference: Meril Diagnostics Pvt. Ltd., MFLRPD-02

Items supplied with:
1.Cassette packaging, each containing 1 device and a desiccant, 30
2.Assay buffer bottles (3.0ml), 2
3.Specimen transfer device (5µl), 30
4.Alcohol swab, 30
5.Lancet, 30
6.Instruction for use, 1

Items required, but not supplied:
Disposable gloves, timer, container for biohazard disposables, sharp box, pencil or pen, venipuncture blood collection materials and precision pipette plus tips

Shelf life:
24 months from the date of manufacturing; do not use beyond its expiry date.

Weight and volume:
Estimated weight: 0.32 Kg
Estimated volume: 0.0016 m³

Storage and transportation condition:
Between 1 - 40°C, protect against humidity and direct sunlight. Do not freeze reagents.

Packaging and labeling:
Primary packaging: All contents of One Step MERISCREEN Mal Pf/Pv Ag, kit of 30 tests
Secondary packaging: One kit One Step MERISCREEN Mal Pf/Pv Ag, 30 tests

General recommendations:
·For guidance on selection criteria for procurement of mRDTs, kindly refer to https://apps.who.int/iris/bitstream/handle/10665/259 870/WHO-CDS-GMP-2018.01-eng.pdf?sequence=1
·Public reports of WHO prequalified in vitro diagnostic products can be found here:
https://extranet.who.int/pqweb/vitro-diagnostics/prequalification-report s/whopr
Follow strictly manufacturer instructions for use of the test procedure (especially adherence to reading time).


Related Products